| Literature DB >> 33803992 |
Jian Xu1, Li Zhou1, Meng Yin1, Zhemin Zhou1,2.
Abstract
The strategy of anaerobic biosynthesis of β-alanine by Escherichia coli (E. coli) has been reported. However, the low energy production under anaerobic condition limited cell growth and then affected the production efficiency of β-alanine. Here, the adaptive laboratory evolution was carried out to improve energy production of E. coli lacking phosphoenolpyruvate carboxylase under anaerobic condition. Five mutants were isolated and analyzed. Sequence analysis showed that most of the consistent genetic mutations among the mutants were related with pyruvate accumulation, indicating that pyruvate accumulation enabled the growth of the lethal parent. It is possible that the accumulated pyruvate provides sufficient precursors for energy generation and CO2 fixing reaction catalyzed by phosphoenolpyruvate carboxykinase. B0016-100BB (B0016-090BB, recE::FRT, mhpF::FRT, ykgF::FRT, mhpB:: mhpB *, mhpD:: mhpD *, rcsA:: rcsA *) was engineered based on the analysis of the genetic mutations among the mutants for the biosynthesis of β-alanine. Along with the recruitment of glycerol as the sole carbon source, 1.07 g/L β-alanine was generated by B0016-200BB (B0016-100BB, aspA::FRT) harboring pET24a-panD-AspDH, which was used for overexpression of two key enzymes in β-alanine fermentation process. Compared with the starting strain, which can hardly generate β-alanine under anaerobic condition, the production efficiency of β-alanine of the engineered cell factory was significantly improved.Entities:
Keywords: CO2 fixation; adaptive laboratory evolution; anaerobic fermentation; energy regulation; β-alanine production
Year: 2021 PMID: 33803992 PMCID: PMC8000549 DOI: 10.3390/microorganisms9030600
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1The metabolic pathway designed for the production of β-alanine. The structure of the expression vector pET24a-panD-AspDH is shown beside the metabolic pathway. GLY: glycerol, G3P: glyceraldehyde-3-P, PEP: phosphoenolpyruvic acid, PYR: pyruvate, OAA: oxaloacetic acid, ASP: aspartic acid, BALA: β-alanine.
E. coli strains and plasmids used in this study.
| Strains | Relevant Characteristics | Source or Reference |
|---|---|---|
| B0016-082BB | B0016-080BB, | Lab stock |
| B0016-082B | B0016-082BB, | This study |
| B0016-090BB | B0016-082BB, | This study |
| B0016-090BBS1 | B0016-090BB, ALE mutant | This study |
| B0016-090BBS2 | B0016-090BB, ALE mutant | This study |
| B0016-090BBS3 | B0016-090BB, ALE mutant | This study |
| B0016-090BBS4 | B0016-090BB, ALE mutant | This study |
| B0016-090BBS5 | B0016-090BB, ALE mutant | This study |
| B0016-100BB | B0016-090BB, | This study |
| B0016-200BB | B0016-100BB, | This study |
| B0016-082B/pET24a- | B0016-082B with pPL451- | This study |
| B0016-200BB/pET24a- | B0016-200BB with pPL451- | This study |
* Genes containing genetic mutations are listed in the genetic mutation library.
Figure 2The method and results of ALE experiment. (a) The process of ALE experiment. (b) The growth curve of the adapted mutants. (c) Consistent mutations among the adapted mutants. (d) Genetic mutations of the mutants. Rings from outer to inner represent the genomic information of B0016-090BBS5, B0016-090BBS4, B0016-090BBS3, B0016-090BBS2, B0016-090BBS1, and B0016-090BB and the reference genome from the NCBI database. S0: B0016-090BB, S1: B0016-090BBS1, S2: B0016-090BBS2, S3: B0016-090BBS3, S4: B0016-090BBS4, S5: B0016-090BBS5. (e) The metabolic pathways associated with the genetic mutation library of the adapted mutant pool. DIH: 2.3-dihydroxycinnamate, HYD: trans- -hydroxy-6-oxononatrienedioate, HYDR: cis-2-hydroxypenta-2,4-dienoate, HYDRO: 4-hydroxy-2-oxopentanoate, PYR: pyruvate, ACE: acetaldehyde, ACOA: acetyl-CoA, EXPI: acyl homoserine lactone, AI: N-(3-oxohexanoyl)-L-homoserine lactone, EXPR: LuxR family transcriptional regulator, quorum-sensing system regulator ExpR, RCSA: LuxR family transcriptional regulator, capsular biosynthesis positive transcription factor.
The genetic mutation library of the adapted mutant pool.
| Genes | Mutations | Amino Acid Mutations |
|---|---|---|
|
| 1737–1737 del a, 1739–1741 del | Frameshift mutation |
|
| A107C b |
|
|
| T278C |
|
|
| T179C, G189C, 76–77 ins GC c, 116–117 del, 120–121 ins AA | Frameshift mutation |
|
| A19G, T27A,33–35 del, 37–38 ins T, 39–40 ins GT, C94G, | Frameshift mutation |
|
| T209A |
|
a Acid bases deletion, b Acid bases substitution, c Acid bases insert, d Amino acid substitution.
Figure 3The profile of growth and production capability of the cell factory constructed with the guide of ALE. The growth curve (a) and the accumulation of pyruvate (b) were compared among B0016-090BB and B0016-100BB in M9 and M9Y media, respectively. The production capacity of B0016-200BB harboring the plasmid pET24a-panD-AspDH (d). Before bioconversion, gfp was applied as a reporter gene to compare the expression strength of tac and the T7 promoter (c) to optimize the expression cassette.
Figure 4Profiles of growth and β-alanine production using strain B0016-200BB/pET24a-panD-AspDH in a 5-L bioreactor. During the fermentation of β-alanine production, genes were induced for expression with the addition of IPTG at 15 h, and oxygen-limited fermentation was conducted at 22 h.